PMDA-2022-0023-V223
Major variation for application PMDA-2022-0023. Major variation: Formulation Change for Tiotropizone — critical change
Variation Number
PMDA-2022-0023-V223
Type
Major
Application
Change
Status
Blocked
Fee
€66,433
Submitted
2024-01-13
Approved
—
Description
Major variation: Formulation Change for Tiotropizone — critical change